← FDA DRUG APPROVALS

FDA ANDA · ANDA062032

ERYPAR

Sponsor: PARKE DAVIS

APPLICATION
ANDA062032
TYPE
ANDA
ORIGINAL APPROVAL
1977-08-24
LATEST ACTION
1977-08-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ERYPARDiscontinued
ERYTHROMYCIN STEARATE EQ 250MG BASE · TABLET · ORAL
ERYPARDiscontinued
ERYTHROMYCIN STEARATE EQ 500MG BASE · TABLET · ORAL

Approval history

1977-08-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →